Position in ABBV
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$7,462,635
+$1,271,348 QoQ
Shares Held
29,656
+4.2% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.69%
of 13F equity value
Holder Rank
#1,071
of 4,167 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TRANSCEND CAPITAL ADVISORS, LLC holds $69,576,548 across 11 Drug Manufacturers - General names. ABBV ranks #4 (10.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
262,453 | $33,725,210 | |
| 2 | JNJ |
Johnson & Johnson
|
43,125 | $10,952,456 | |
| 3 | LLY |
ELI LILLY & Co
|
6,902 | $8,278,466 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
29,656 | $7,462,635 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
55,185 | $3,179,759 | |
| 6 | AMGN |
Amgen Inc
|
4,077 | $1,476,363 | |
| 7 | NVS |
Novartis AG
|
8,348 | $1,308,298 | |
| 8 | AZN |
Astrazeneca PLC
|
6,659 | $1,262,679 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,462,635 | 29,656 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $6,191,287 | 28,467 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $6,724,003 | 29,428 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $7,584,324 | 32,756 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $7,123,909 | 38,379 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $8,836,925 | 42,177 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $7,651,762 | 43,060 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $9,155,765 | 46,363 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $7,928,855 | 46,227 | Shares | Sole | 2024-07-02 | |
| 2024-03-31 | $5,220,442 | 28,668 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $3,392,758 | 21,893 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $3,301,529 | 22,149 | Shares | Sole | 2023-10-31 | |
| 2023-06-30 | $3,017,278 | 22,395 | Shares | Sole | 2023-07-13 | |
| 2023-03-31 | $3,515,064 | 22,056 | Shares | Sole | 2023-04-12 | |
| 2022-12-31 | $3,631,538 | 22,471 | Shares | Sole | 2023-01-20 | |
| 2022-09-30 | $3,103,606 | 23,125 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $3,521,607 | 22,993 | Shares | Sole | 2022-07-12 | |
| 2022-03-31 | $3,782,998 | 23,336 | Shares | Sole | 2022-04-20 | |
| 2021-12-31 | $3,049,614 | 22,523 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $2,362,353 | 21,900 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $2,171,023 | 19,274 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,931,077 | 17,844 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $1,977,024 | 18,451 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $1,365,790 | 15,593 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $1,409,177 | 14,353 | Shares | Defined | 2020-08-05 | |
| 2020-03-31 | $1,359,762 | 17,847 | Shares | Defined | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||